Shay Capital’s GSK GSK Stock Holding History

Shay Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-90,500	Closed	-$3.18M	–	474
2022 Q4	$3.18M	Buy	+90,500	New	+$3.01M	0.98%	22
2022 Q3	–	Sell	-183,200	Closed	-$10.1M	–	406
2022 Q2	$10.1M	Buy	+183,200	New	+$10.1M	2.04%	5

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Shay Capital's GSK Position: Q2 2023 in Review

Shay Capital sold out of GSK (GSK) in Q2 2023, closing a stake of 16,000 shares — an estimated $569K sold.

Shay Capital first reported a position in GSK in Q2 2022 and held it in 3 quarters. The position peaked at $4.14M in Q4 2022. 827 funds tracked by Wall St. Rank hold GSK as of Q2 2023.

Shay Capital reported no remaining GSK position as of Q2 2023 after selling out during the quarter.
Shay Capital sold 16,000 GSK shares in Q2 2023, an estimated $569K.
Shay Capital first reported a position in GSK in Q2 2022 and held it in 3 quarters.
Shay Capital's GSK position peaked at $4.14M in Q4 2022.
827 funds tracked by Wall St. Rank held GSK as of Q2 2023.

Based on Shay Capital's 13F filing for Q2 2023, filed 14 Aug 2023.